Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma

International Journal of Cancer

Volumn 79, Issue 3, 1998, Pages 294-299

  Volm, Manfred ^a   Koomägi, Reet ^a   Rittgen, Werner ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL CYCLE PROTEINS; CYCLIN A; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETINOBLASTOMA PROTEIN; TIME FACTORS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 2642607872     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980619)79:3<294::AID-IJC15>3.0.CO;2-8     Document Type: Article

References (21)

1. BETTICHER, D.C., HEIGHWAY, J., HASLETON, P.S., ALTERMATT, J.H., RYDER, W.D.J., CERNY, T. and THATCHER, N., Prognostic significance of CCND1 (cyclin D1) overexpression in primary non-small-cell lung cancer. Brit. J. Cancer, 73, 294-300 (1996).
2. CARR, D.T. and MOUNTAIN, C.F., Staging lung cancer. In: M.J. Straus (ed.), Lung cancer. Clinical diagnosis and treatment, pp. 151-161, Grune and Stratton, New York (1977).
3. CORDON-CARDO, C., Mutation of cell-cycle regulators. Biological and clinical implications for human neoplasia (Review). Amer. J. Pathol., 147, 545-560 (1995).
4. DOWDY, S.F., HINDS, P.W., LOUIE, K., REED, S.I., ARNOLD, A. and WEINBERG, R.A., Physical interaction of the retinoblastoma protein with human D cyclins. Cell, 73, 499-505 (1993).
5. GOODMAN, L.A. and KRUSKAL, W.H., Measures of association for cross classifications I. II and III. J. Amer. statist. Ass., 49, 732-764 (1954), 54, 123-163 (1959) and 58, 310-364 (1963).
6. GOODMAN, L.A. and KRUSKAL, W.H., Measures of association for cross classifications I. II and III. J. Amer. statist. Ass., 49, 732-764 (1954), 54, 123-163 (1959) and 58, 310-364 (1963).
7. GOODMAN, L.A. and KRUSKAL, W.H., Measures of association for cross classifications I. II and III. J. Amer. statist. Ass., 49, 732-764 (1954), 54, 123-163 (1959) and 58, 310-364 (1963).
8. HIEBERT, S.W., Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2-promoter repression and pRh-mediated growth suppression. Mol. cell. Biol., 13, 3384-3391 (1993).
9. JOHNSON, D.G., RICHIE, E.R. and CONTI, C.J., The cell cycle and cancer. Cancer Bull., 47, 480-485 (1995).
10. JOHNSON, D.J., SCHWARTZ, J.K., CRESS, W.D. and NEVINS, J.R., Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (Lond.), 365, 349-352 (1993).
11. KALBFLEISCH, I. and PRENTICE, L., Analysis of failure time data. Wiley, New York (1980).
12. LEW, D.J. and KORNBLUTH, S., Regulatory roles of cyclin-dependent kinase phosphorylation in cell-cycle control. Curr. Opin. Cell Biol., 8, 795-804 (1996).
13. MICHALIDES, R., VAN VEELEN, N., HART, A., LOFTUS, B., WIENTJENS, E. and BALM, A., Over-expression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous-cell carcinomas of the head and neck. Cancer Res., 55, 975-978 (1995).
14. 1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell, 65, 381-393 (1991).
15. NAITOH, H., SHIBATA, J., KAWAGUCHI, A., KODAMA, M. and HATTORI, T., Over-expression und localization of cyclin-D1 mRNA and antigen in esophageal cancer. Amer. J. Pathol. 146, 1161-1169 (1995).
16. REISSMANN, P.T., KOGA, H., TAKAHASHI, R., FIGLIN, R.A., HOLMES, E.C., PIANTADOSI, S., CORDON-CARDO, C. and SLAMON, D.J., Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. Oncogene, 8, 1913-1919 (1993).
17. SESHADRI, R., LEE, C.S.L., HUI, R., MCCAUL, K., HORSFALL, D.J. and SUTHERLAND, R.L., Cyclin-D1 amplification is not associated with reduced overall survival in primary breast cancer, but may predict early relapse in patients with features of good prognosis. Clin. Cancer Res., 2, 1177-1184 (1996).
18. SHIMIZU, E. and 12 others, Rb-protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small-cell carcinoma, and mesothelioma. Oncogene, 9, 2441-2448 (1994).
19. 1 progression. Oncogene, 9, 2663-2674 (1994).
20. VOLM, M., BAK, M., EFFERTH, T., LATHAN, B. and MATTERN, J., Immunocyto-chemical detection of a resistance-associated glyeoprotein in tissue-culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res., 8, 531-536 (1988).
21. XU, H-J., QUINLAN, D.C., DAVIDSON, A.G., HU, S-X., SUMMERS, C.L., LI, J. and BENEDICT, W.F., Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. Nut. Cancer Inst., 86, 695-699 (1994).